EXECUTIVE SUMMARY Results of recent research show a direct correlation between simulator training for OB/GYNs and a reduction in medical malpractice claim rates. Claim rates declined from 11.2 claims per 100 physician coverage years before simulation training to 5.7 claims. Similar effectiveness can be expected from simulation training in other areas of medicine. A simulation […]

Dr. Kleanthis Xanthopoulos, co-founder,  Chairman  and CEO of Shoreline Biosciences, discusses the development of genetically engineered induced pluripotent stem cell (iPSC)-derived allogeneic natural killer (NK) and macrophage products that are intelligently designed for greater  specificity, potency and persistence, overcoming the limitations of early cell therapies, for use in oncology and regenerative medicine. Kleanthis is a serial […]

Dr Seth Lederman is a physician-scientist, entrepreneur, and CEO of Tonix Pharmaceuticals. He talks to Lu Rahman about Tonix Pharmaceuticals’ mission to research and manufacture small molecules and biologics for the treatment of CNS and immunological conditions.  Since its formation in 2011, Tonix Pharmaceuticals has harnessed the power of clinical research and strategic collaborations to develop novel in-house and in-licensed compounds for […]